Clinical Trial Update: Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease. [NA]

View source ↗

Summary

A completed clinical trial update evaluating how renin-angiotensin blocking drugs may maximize benefits in diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• ACE inhibitors
• Angiotensin II receptor blockers (ARB)

Snippet

Sponsor: Stanford University | Conditions: Diabetic Nephropathy | NA | Status: COMPLETED